What is intervertebral disc disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Intervertebral Disc Disease?

Intervertebral disc disease (IVD disease) is a naturally occurring degenerative process characterized by progressive loss of disc structural integrity, including nucleus pulposus depressurization, annular tears and delamination, and endplate fractures, which can lead to pathological states such as disc herniation, spinal stenosis, or mechanical instability. 1

Pathophysiology and Structural Changes

The degenerative cascade involves predictable anatomical deterioration:

  • Nucleus pulposus changes include loss of pressurization, decreased collagen concentration, and loss of distinction from the surrounding annulus fibrosus 1
  • Annular fibrosus degradation manifests as delamination and tears at both microscopic and macroscopic scales 1
  • Cartilaginous endplate damage presents as fractures and clefts in the extracellular matrix 1
  • Cellular level changes include senescence and apoptosis of nucleus pulposus cells, progressive extracellular matrix degeneration, and inflammatory responses 2

Clinical Manifestations

IVD disease exists on a spectrum from asymptomatic degeneration to symptomatic pathology:

Asymptomatic Degeneration

  • Disc abnormalities are common on MRI in asymptomatic patients, with 20-28% prevalence of herniation in people without symptoms 3
  • Degenerative changes correlate poorly with symptoms and are considered nonspecific findings 3

Symptomatic Pathological States

When functional failure occurs, specific clinical phenotypes emerge:

Disc Herniation:

  • Herniation of nucleus pulposus through the annulus fibrosus causes nerve root compression 3
  • Presents with radiculopathy (sciatica) - pain radiating below the knee in sciatic nerve distribution 3, 4
  • Unilateral dermatomal leg pain with positive straight-leg raise test (30-70 degrees) 3, 4
  • Associated neurological deficits include sensory impairment, weakness, or diminished reflexes in nerve root distribution 3, 4
  • Symptomatic patients show 57% prevalence of herniation with low back pain and 65% with radiculopathy 3

Spinal Stenosis with Neurogenic Claudication:

  • Narrowing of spinal canal causing cauda equina compression 3
  • Bilateral leg pain provoked by walking or standing, relieved by sitting or forward spinal flexion 3, 4
  • Distinct from radiculopathy by its bilateral, positional nature 4

Cauda Equina Syndrome (severe, emergent):

  • Massive central disc herniation causing compression of sacral/lumbar nerve roots 3
  • Presents with urinary retention or incontinence, bilateral lower extremity weakness, saddle anesthesia, and absent lower limb reflexes 3
  • Most commonly occurs at L4-L5 and L5-S1 levels 3

Mechanical Instability and Degenerative Spondylolisthesis:

  • Loss of structural support leading to abnormal spinal motion 1

Diagnostic Approach

MRI lumbar spine without contrast is the imaging study of choice for evaluating symptomatic disc disease, as it accurately depicts soft-tissue pathology, vertebral marrow, and spinal canal patency 3

Imaging Indications:

  • Patients with subacute/chronic low back pain or radiculopathy who have failed 6 weeks of conservative therapy 3
  • Physical examination signs of nerve root irritation in surgical or interventional candidates 3
  • Suspected cauda equina syndrome requires urgent MRI assessment 3

Diagnostic Pitfalls:

  • Size and type of disc herniation do not correlate with patient outcomes 3
  • Location and presence of nerve root compression alone do not predict prognosis 3
  • High prevalence of asymptomatic disc abnormalities (20-28%) means imaging findings must correlate with clinical presentation 3, 5

Etiological Factors

Multiple factors contribute to disc degeneration:

  • Biological aging and normal physiological loading over lifetime 1
  • Genetic predisposition 2
  • Mechanical injury 2
  • Malnutrition 2

Treatment Spectrum

Management ranges from conservative to surgical intervention:

  • Conservative treatment remains the mainstay for most patients, as disc pathology is commonly self-limited 1
  • Surgical intervention focuses on neural decompression and motion segment stabilization when indicated 1
  • Lumbar fusion is not recommended as routine treatment following primary disc excision for isolated herniated discs causing radiculopathy 3
  • Fusion may be considered in patients with herniated discs who have significant chronic axial back pain, work as manual laborers, have severe degenerative changes, or have instability associated with radiculopathy 3

References

Research

Intervertebral disc degeneration.

Nature reviews. Disease primers, 2026

Research

Treatment of Intervertebral Disc Degeneration.

Orthopaedic surgery, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Distinguishing Neurogenic Claudication from Lumbar Radiculopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the etiology of Intervertebral Disc Syndrome (IVDS)?
What is the appropriate management for a 37-year-old female with a mild annular disc bulge and left paracentral disc protrusion at L4 and mild left facet arthropathy at L5?
What are the selection criteria for lumbar disc arthroplasty instead of spinal fusion in a patient with a single symptomatic degenerative disc at L4‑5 or L5‑S1?
What NSAID (e.g., ibuprofen) and acetaminophen (Tylenol) dosing regimen and frequency is appropriate for an adult patient with a cervical herniated disc and no contraindications?
Do the MRI and X‑ray findings of mild spondylosis, facet arthropathy, disc bulges, and mild central canal stenosis at L4‑L5 explain the chronic low‑back pain in a 27‑year‑old obese female, and what underlying disease processes could cause such early degenerative changes?
How should fluid resuscitation be performed in a hypernatremic patient, taking into account the patient's volume status?
What premedications and dosing are recommended before administering intravenous immunoglobulin (IVIG) to a patient with Guillain‑Barré syndrome?
In a patient with hypermobile Ehlers‑Danlos syndrome who regularly does strength training with a personal trainer, brisk walks, light yoga, and physical‑therapy, should a beta‑adrenergic blocker be added to manage fatigue and orthostatic tachycardia?
Do approximately 90 % of individuals with hypermobile Ehlers‑Danlos syndrome exhibit mild, widespread autonomic dysfunction, and what are the recommended screening and first‑line non‑pharmacologic treatments?
Is a daily dose of 7.5 mg methotrexate appropriate, or should methotrexate be administered weekly?
Can you help me prepare a medical slide presentation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.